Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Bernard Grelon lawyer for the French state attends a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Christophe Clerc lawyer for NovAsco attends a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

A general view during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Yan Amadoro representative of NovAsco employees attends a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

A general view during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Yan Amadoro representative of NovAsco employees attends a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Bernard Grelon lawyer for the French state attends a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Christophe Clerc lawyer for NovAsco attends a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

A view of Sebastien Martin with Bernard Grelon lawyer for the French state and Yan Amadoro representative of NovAsco employees during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Sebastien Martin At Press Conference - Paris

Sebastien Martin speaks during a press conference on legal action against the investment fund Greybull in Paris, France, on January 19, 2026. Photo by Jean-Bernard Vernier/JBV News/ABACAPRESS.COM

E

Briefings run at press center of Verkhovna Rada

Leader of the European Solidarity political party Petro Poroshenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Prime Minister and Minister of Economy of Ukraine Yuliia Svyrydenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

Leader of the European Solidarity political party Petro Poroshenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

Leader of the European Solidarity political party Petro Poroshenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Minister of Economy of Ukraine Oleksii Sobolev, Deputy Minister of Economy of Ukraine - Trade Representative of Ukraine Taras Kachka (L to R), First Deputy Prime Minister - Minister of Economy of Ukraine Yuliia Svyrydenko are seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

Leader of the European Solidarity political party Petro Poroshenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Minister of Economy of Ukraine Oleksii Sobolev, Deputy Minister of Economy of Ukraine - Trade Representative of Ukraine Taras Kachka (L to R), First Deputy Prime Minister - Minister of Economy of Ukraine Yuliia Svyrydenko are seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Prime Minister and Minister of Economy of Ukraine Yuliia Svyrydenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Prime Minister and Minister of Economy of Ukraine Yuliia Svyrydenko speaks during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Prime Minister and Minister of Economy of Ukraine Yuliia Svyrydenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

First Deputy Minister of Economy of Ukraine Oleksii Sobolev, Deputy Minister of Economy of Ukraine - Trade Representative of Ukraine Taras Kachka (L to R), First Deputy Prime Minister - Minister of Economy of Ukraine Yuliia Svyrydenko are seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Briefings run at press center of Verkhovna Rada

Leader of the European Solidarity political party Petro Poroshenko is seen during a briefing at the parliamentary press center after voting to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcast of the Verkhovna Rada of Ukraine session during which a total of 338 MPs voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcasting of the speech of Chairman of the Committee on Foreign Policy and Interparliamentary Cooperation, MP Oleksandr Merezhko at the parliamentary session during which MPs voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Scoreboard with the results of the vote on the ratification of the agreement to establish a joint investment fund between Ukraine and the United States during the session of the Verkhovna Rada of Ukraine, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Cameramen work in the press box during a parliamentary session, where a total of 338 MPs voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcasting of the speech of the Chairman of the Verkhovna Rada of Ukraine Ruslan Stefanchuk at the parliamentary session during which MPs voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcast of the vote on the ratification of the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcast of the Verkhovna Rada of Ukraine session, which voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcast of the Verkhovna Rada of Ukraine session during which MPs voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Verkhovna Rada votes to ratify agreement on subsoil with United States

Broadcasting of the speech of the Chairman of the Verkhovna Rada of Ukraine Ruslan Stefanchuk at the parliamentary session during which MPs voted to ratify the agreement on the establishment of a joint investment fund between Ukraine and the United States, at the parliamentary press center, Kyiv, Ukraine, on May 8, 2025 (Photo by Yevhen Kotenko/Ukrinform)

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM